Clinical Trial Update: AURA-2: Augmenting Urinary Reflex Activity [NA]

View source ↗

Summary

The AURA-2 clinical trial investigating augmentation of urinary reflex activity for overactive bladder and urge incontinence has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urge Incontinence

Drugs mentioned

• Amber Therapeutics Investigational Agent

Snippet

Sponsor: Amber Therapeutics Ltd | Conditions: Overactive Bladder, Urge Incontinence | NA | Status: COMPLETED